Tokyo Tape
Sign in
← Ono Pharmaceutical

Annual report

4528.TEDINET S100OBYA
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥361.4bn2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥309.3bn2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥292.4bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥288.6bn2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥261.8bn2017-04-01 → 2018-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥103.2bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥98.3bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Profit before tax¥105.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥100.9bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax¥79.7bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥65.1bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥63.9bn2017-04-01 → 2018-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥80.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥75.4bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥59.7bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥51.5bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥50.3bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥80.7bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥75.5bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Total assets¥739.2bnat 2022-03-31Cons.Assets IFRS
Total assets¥745.4bnat 2021-03-31Cons.Assets IFRS
Total assets¥673.4bnat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥655.1bnat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥609.2bnat 2018-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥77.5bnat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥105.7bnat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥661.7bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥639.7bnat 2021-03-31Cons.Equity IFRS
Net assets / equity¥568.0bnat 2020-03-31dCons.Equity IFRS
Equity (owners)¥655.9bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥634.1bnat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥562.5bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥557.4bnat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥524.4bnat 2018-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥69.1bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥61.0bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.0bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥60.0bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥65.3bnat 2018-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥61.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥74.0bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥74.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥66.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥15.7bn2017-04-01 → 2018-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow¥6.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥57.6bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥10.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥49.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥34.2bn2017-04-01 → 2018-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥60.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥24.8bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥54.7bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥22.3bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥62.5bn2017-04-01 → 2018-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥162.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥151.112020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥118.472019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥100.252018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥972017-04-01 → 2018-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥162.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥151.092020-04-01 → 2021-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥118.452019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥100.242018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥96.992017-04-01 → 2018-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,343.4at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,270.45at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,126.95at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,084.08at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,019.97at 2018-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio88.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.1%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio83.5%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.1%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio86.1%at 2018-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE12.5%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE12.6%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE10.7%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE9.5%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE9.6%2017-04-01 → 2018-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees3,687at 2022-03-31Cons.Number of employees
Employees3,607at 2021-03-31Cons.Number of employees
Employees3,560at 2020-03-31dCons.Number of employees
Employees3,555at 2019-03-31dCons.Number of employees
Employees3,480at 2018-03-31dCons.Number of employees
Revenue¥357.0bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥305.2bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥286.2bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥286.4bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥260.2bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥119.9bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥84.9bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥121.1bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥86.8bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥70.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥58.3bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥47.2bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥124.4bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥101.2bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥94.6bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥76.9bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥69.3bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥55.7bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥44.4bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥661.9bnat 2022-03-31StandaloneAssets
Total assets¥669.6bnat 2021-03-31StandaloneAssets
Total assets¥599.4bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥591.4bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥551.2bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥62.7bnat 2022-03-31StandaloneLiabilities
Total liabilities¥95.1bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥599.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥574.6bnat 2021-03-31StandaloneNet assets
Net assets / equity¥507.7bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥507.1bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥477.3bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥102.6bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥90.8bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥190.512021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥154.12020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥137.592019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥108.392018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥85.612017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥190.492021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥154.082020-04-01 → 2021-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥137.572019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥108.382018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥85.62017-04-01 → 2018-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥562021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥452019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥452018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥452017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,226.79at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,150.68at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,016.83at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥985.91at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥928.03at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio90.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio84.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio85.7%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio86.6%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.1%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE14.2%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE13.7%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE11.3%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE9.3%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued528,341,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued543,341,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued543,341,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees3,354at 2022-03-31StandaloneNumber of employees
Employees3,319at 2021-03-31StandaloneNumber of employees
Employees3,287at 2020-03-31dStandaloneNumber of employees
Employees3,284at 2019-03-31dStandaloneNumber of employees
Employees3,199at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentemployeesat 2022-03-313687 pure
Pharmaceutical Productsreportable segmentemployeesat 2022-03-313354 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,914
ItemContextValueUnit
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-12300000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_RevaluationReserveForLandMember898000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-11403000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-2000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember-11404000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember-29970000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember36031000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-12300000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_RevaluationReserveForLandMember898000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-11403000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-2000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember24627000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-74635000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember546273000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember56598000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_RevaluationReserveForLandMember-3815000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember52782000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember137000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember599192000000JPY
Doctor to doctor event and explanatory meeting related expenses sgaPrior1YearDuration_NonConsolidatedMember4151000000JPY
Doctor to doctor event and explanatory meeting related expenses sgaCurrentYearDuration_NonConsolidatedMember4148000000JPY
Promotion expenses sgaPrior1YearDuration_NonConsolidatedMember6889000000JPY
Promotion expenses sgaCurrentYearDuration_NonConsolidatedMember11476000000JPY
Salaries sgaPrior1YearDuration_NonConsolidatedMember12412000000JPY
Salaries sgaCurrentYearDuration_NonConsolidatedMember12741000000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember1493000000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember-573000000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember3326000000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember3369000000JPY
Provision for directors bonuses sgaPrior1YearDuration_NonConsolidatedMember84000000JPY
Provision for directors bonuses sgaCurrentYearDuration_NonConsolidatedMember130000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember591000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember680000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember78072000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember81832000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-06-24
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第74期(自　2021年４月１日　至　2022年３月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)小野薬品工業株式会社
Company name in english cover pageFilingDateInstantONO　PHARMACEUTICAL　CO.,　LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　相　良 　暁
Address of registered headquarter cover pageFilingDateInstantText · Plus
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪市中央区久太郎町一丁目８番２号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪(06)6263局5670番
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経理部長　　長　濱　一　弘
Place for public inspection cover page (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass